Antimicrobials, Multiple Drug Resistance & Antibiotics Resistance

Neglected tropical diseases include microbial, parasitic and viral diseases. Toxoplasmosis is number one cause of foodborne hospitalization and congenital diseases aff ecting 60 million people in USA and 1/3rd of global population. About 1700 patients suff er from Malaria in USA each year, and millions are infected in South Asia and Africa. It is estimated that 600-800 million people worldwide to be infected with hookworms which cause severe anemia, growth retardation and eosinophilic enteritis. Dengue (break back) hemorrhagic fever is endemic in Far East and back again in Southern States and Hawaii. HIV/AIDS aff ects about 1.1 million in USA and another 1 million in China. About 1 million people suff er from multidrug resistant Mycobacterium tuberculosis in China, and it has become a major public health problem. Th e estimated cost to treat a multidrug resistant patient is over 200 times more than those infected with non-resistant tuberculosis. Th e funding for global neglected tropical diseases was started in 2006 with $15 million supported by USA. Th is funding has increased to $100 million in 2017 and current requested budget is $75 million for 2018. Th is integrative presentation will discuss a recent visit to Sun Yat Sen University Medical Center and Zhuhai Affi liated Hospitals located in the exotic tropical Southern China and some of the neglected tropical diseases endemic in the area. In addition, the presentation aims to alarm the need for scientific collaboration between 2 countries to advance the knowledge of tropical and infectious diseases in developing eff ective  therapeutic antimicrobial, preventive measures and diagnostic tools, in order to end the humans’ suff erings.